Genome-wide association analysis of type 2 diabetes in the EPIC-InterAct study.


Journal

Scientific data
ISSN: 2052-4463
Titre abrégé: Sci Data
Pays: England
ID NLM: 101640192

Informations de publication

Date de publication:
13 11 2020
Historique:
received: 05 05 2020
accepted: 04 09 2020
entrez: 14 11 2020
pubmed: 15 11 2020
medline: 13 1 2021
Statut: epublish

Résumé

Type 2 diabetes (T2D) is a global public health challenge. Whilst the advent of genome-wide association studies has identified >400 genetic variants associated with T2D, our understanding of its biological mechanisms and translational insights is still limited. The EPIC-InterAct project, centred in 8 countries in the European Prospective Investigations into Cancer and Nutrition study, is one of the largest prospective studies of T2D. Established as a nested case-cohort study to investigate the interplay between genetic and lifestyle behavioural factors on the risk of T2D, a total of 12,403 individuals were identified as incident T2D cases, and a representative sub-cohort of 16,154 individuals was selected from a larger cohort of 340,234 participants with a follow-up time of 3.99 million person-years. We describe the results from a genome-wide association analysis between more than 8.9 million SNPs and T2D risk among 22,326 individuals (9,978 cases and 12,348 non-cases) from the EPIC-InterAct study. The summary statistics to be shared provide a valuable resource to facilitate further investigations into the genetics of T2D.

Identifiants

pubmed: 33188205
doi: 10.1038/s41597-020-00716-7
pii: 10.1038/s41597-020-00716-7
pmc: PMC7666191
doi:

Types de publication

Dataset Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

393

Subventions

Organisme : Medical Research Council
ID : MC_UU_00006/1
Pays : United Kingdom
Organisme : RCUK | Medical Research Council (MRC)
ID : MC_UU_12015/1
Pays : International
Organisme : Wellcome Trust (Wellcome)
ID : WT206194
Pays : International
Organisme : RCUK | Medical Research Council (MRC)
ID : MC_UU_12015/5
Pays : International
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00006/3
Pays : United Kingdom

Références

Genet Epidemiol. 2016 May;40(4):304-14
pubmed: 27061298
Am J Epidemiol. 2013 Oct 1;178(7):1177-84
pubmed: 23863760
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
PLoS Med. 2014 May 20;11(5):e1001647
pubmed: 24845081
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Eur J Hum Genet. 2017 Jun;25(7):854-862
pubmed: 28594416
Nat Genet. 2018 Nov;50(11):1505-1513
pubmed: 30297969
Curr Nutr Rep. 2014;3(4):355-363
pubmed: 25383255
Nature. 2007 Feb 22;445(7130):881-5
pubmed: 17293876
Sci Data. 2020 Nov 13;7(1):393
pubmed: 33188205
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Biostatistics. 2011 Jan;12(1):1-17
pubmed: 20543033
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Diabetologia. 2011 Sep;54(9):2272-82
pubmed: 21717116

Auteurs

Lina Cai (L)

MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.

Eleanor Wheeler (E)

MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.

Nicola D Kerrison (ND)

MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.

Jian'an Luan (J)

MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.

Panos Deloukas (P)

Clinical Pharmacology Centre, Queen Mary University of London, London, United Kingdom.

Paul W Franks (PW)

Department of Clinical Sciences, Clinical Research Center, Skåne University Hospital, Lund University, 20502, Malmö, Sweden.
Department of Public Health and Clinical Medicine, Umeå University, 90187, Umeå, Sweden.

Pilar Amiano (P)

Ministry of Health of the Basque Government, Public Health Division of Gipuzkoa, Biodonostia Health Research Institute, Donostia-San Sebastian, Spain.

Eva Ardanaz (E)

Navarra Public Health Institute, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Catalina Bonet (C)

Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet de Llobregat, Barcelona, 08908, Spain.

Guy Fagherazzi (G)

Digital Epidemiology and e-Health Research Hub, Department of Population Health, Luxembourg Institute of Health, 1A-B, rue Thomas Edison, L-1445, Strassen, Luxembourg.
Center of Epidemiology and Population Health UMR 1018, Inserm, Paris South - Paris Saclay University, Gustave Roussy Institute, Villejuif, France.

Leif C Groop (LC)

Department of Clinical Sciences, Clinical Research Center, Skåne University Hospital, Lund University, 20502, Malmö, Sweden.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany.

José María Huerta (JM)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.

Giovanna Masala (G)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.

Peter M Nilsson (PM)

Department of Clinical Sciences, Clinical Research Center, Skåne University Hospital, Lund University, 20502, Malmö, Sweden.

Kim Overvad (K)

Department of Public Health, Aarhus University, Bartholins Allé 2, DK-8000, Aarhus C, Denmark.
Department of Cardiology, Aalborg University Hospital, Sdr. Skovvej 15, DK-9000, Aalborg, Denmark.

Valeria Pala (V)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Salvatore Panico (S)

Dipartimento di Medicina Clinica e Chirurgia, Federico II University, via Pansini 5, 80131, Naples, Italy.

Miguel Rodriguez-Barranco (M)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
Instituto de Investigación Biosanitaria ibs.Granada, Granada, Spain.

Olov Rolandsson (O)

Department of Public Health and Clinical Medicine, Umeå University, 90187, Umeå, Sweden.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.
Institute of Nutrition Science, University of Potsdam, Nuthetal, Germany.

Annemieke M W Spijkerman (AMW)

National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA, Bilthoven, The Netherlands.

Anne Tjonneland (A)

Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, Azienda Sanitaria Provinciale No 7, Piazza Igea Nr 1, 97100, Ragusa, Italy.
Associazone Iblea per la Ricerca Epidemiologica -Organizazione Non Lucrativa di Utilità Sociale, Piazza Amcione No 2, 97100, Ragusa, Italy.

Yvonne T van der Schouw (YT)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3584 CG, Utrecht, the Netherlands.

Stephen J Sharp (SJ)

MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.

Nita G Forouhi (NG)

MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.

Elio Riboli (E)

School of Public Health, Imperial College London, London, United Kingdom.

Mark I McCarthy (MI)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Oxford Centre for Diabetes, University of Oxford, Oxford, United Kingdom.
Oxford NIHR Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom.
1 DNA Way, South San Francisco, CA, 94080, USA.

Inês Barroso (I)

University of Exeter Medical School, Exeter, United Kingdom.

Claudia Langenberg (C)

MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.

Nicholas J Wareham (NJ)

MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom. nick.wareham@mrc-epid.cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH